Granules Pharmaceuticals Inc.

Granules Pharmaceuticals Inc. is a 100% subsidiary of Granules India, located in Chantilly, Virginia. The company is a US FDA and DEA-approved facility that specializes in the manufacturing of low-volume, oral solid dosage forms, including tablets, capsules, oral solutions, and powders. Granules Pharmaceuticals Inc. has established R&D and manufacturing capabilities, and its portfolio consists of complex, low-volume products, as well as medium to high-volume, integrated products.